March 30, 2009 – Lantheus Medical Imaging Inc. released at ACC 2009 new data regarding the use of DEFINITY Vial For (Perflutren Lipid Microsphere) Injectable Suspension that finds significant survival benefit for critically ill patients undergoing contrast-enhanced echocardiography.
